JezK

Edit File: 1628280339.M81152P2988686.mocha3025.mochahost.com,S=109684,W=112015:2,S

Envelope-to: hadi@jack.ngo,
 dr.safar@jack.ngo,
 fatima.qasimi@jack.ngo,
 finance.manager@jack.ngo,
 logistic.manager@jack.ngo,
 nooromari@jack.ngo,
 takal@jack.ngo
Delivery-date: Fri, 06 Aug 2021 16:05:39 -0400
From: <ahmad@jack.ngo>
To: <dr.safar@jack.ngo>
Cc: <hadi@jack.ngo>,
	<logistic.manager@jack.ngo>,
	<fatima.qasimi@jack.ngo>,
	<finance.manager@jack.ngo>,
	<takal@jack.ngo>,
	<nooromari@jack.ngo>
References: <007701d719a6$5153c930$f3fb5b90$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAADn+wNFvFnYSoPoAS9WN/N/AQAAAAA=@jack.ngo> <005e01d74040$648d85c0$2da89140$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAAC/LKTvAmgVSJSNjnP06dt3AQAAAAA=@jack.ngo> <004301d788fa$5e3f3080$1abd9180$@jack.ngo>
In-Reply-To: <004301d788fa$5e3f3080$1abd9180$@jack.ngo>
Subject: RE: Rejected and not received medicine
Date: Sat, 7 Aug 2021 00:35:33 +0430
Message-ID: <009c01d78afe$6c78a090$4569e1b0$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_009D_01D78B24.247463D0"
Thread-Index: AQIwKTvpzDoM5QD4M3IF3aqBB1HSrgHFTt8gAVPZ+SsBiyelvwJJMJL6qn4+FqA=
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_009E_01D78B24.247463D0"

------=_NextPart_001_009E_01D78B24.247463D0
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

We have to plan a meeting on this issue to find the solution way; at =
first we have to draft the assessment report then we will work on this =
issue please remind me .

=20

With Best Regards,

=20

Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D MD,PGD (Leadership) PGD (NMD), PMP

Program Director=20

Just for Afghan Capacity and Knowledge       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =
=D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20

Address: First Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 08

Ph: +93 +93(0)748480909=20

Email: ahmad <mailto:ahmad@jack.ngo> @jack.ngo =20

Website:www.jack.ngo=20

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

This e-mail and any files transmitted with it may contain privileged or =
confidential information. It is solely for use by the individual for =
whom it is intended, even if addressed incorrectly. If you received this =
e-mail in error, please notify the sender; do not disclose copy, =
distribute, or take any action in reliance on the contents of this =
information; and delete it from your system. Any other use of this =
e-mail is prohibited. The views expressed herein are those of the author =
and do not necessarily reflect the views or policies of jack =
(Afghanistan). Electronic transmissions may be recorded and =
monitored.For Verification Please Read the Barcode Reader. =20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: dr.safar@jack.ngo [mailto:dr.safar@jack.ngo]=20
Sent: Wednesday, August 4, 2021 11:01 AM
To: ahmad@jack.ngo
Cc: hadi@jack.ngo; logistic.manager@jack.ngo; fatima.qasimi@jack.ngo; =
finance.manager@jack.ngo; takal@jack.ngo; nooromari@jack.ngo
Subject: RE: Rejected and not received medicine

=20

Dear Dr Ahmad

=20

As per below emails and justifications, 155 Flagyl syrups and 30 Serum =
saline were not delivered to the supplier according to our exchange =
plan.

=20

The exchange plan was to:=20

*       450 Flagyl Syrup should have been replaced with 450 Flagyl =
solution

*       2250 saline syrum of 500 Mile liter should have been replaced to =
2250 Saline syrum 1000 Mile Liter

=20

295 flagyl syrup was delivered to the supplier, however, 155 was missed =
from Pharmacy assistant Mr Hakim Mangal as he said AOGs did not give =
them the exchanged Flagyl syrups.

=20

From 2250 Syrums, total 2220 Syrums were delivered to supplier. 30 =
syrums remained from the exchange, the reasons was when the first supply =
happened to Jan Qataghan, the syrums of 1000 Mile Liter was sent, =
however, the exchange of it was not brought back to stock. Later AOGs =
only gave them 420 syrums, 30 was used by FATP staff.

=20

Total: 155 Flagyl syrup and 30 Saline 500 Mile liter was left and the =
reason was that Mr Hakim Mangal sent the medicine to FATPs and did not =
bring back it=E2=80=99s exchange, he said AOGs did not permit.

The real was that Mr Mangal reported the issue after 3 days. When the =
issue was followed up, FATP staff said we have submitted and there were =
no documents for hand over/take over. Not having a clear document for =
takeover of medicine was the fault of Pharmacy assistant.

=20

Conclusion:  I would like to kindly request from top management team =
that declare their decision on the above mentioned issue. As it was =
raised by myself even months ago and there is no clear decision taken =
until now.

=20

Thanks in advance

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Emergency projects focal point / COVID-19 Vaccination technical focal =
point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93790807013 =E2=80=93 +93777 =
469 663

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Website:www.jack.ngo

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Monday, June 21, 2021 8:30 AM
To: fatima.qasimi@jack.ngo <mailto:fatima.qasimi@jack.ngo>=20
Cc: hadi@jack.ngo <mailto:hadi@jack.ngo> ; dr.safar@jack.ngo =
<mailto:dr.safar@jack.ngo> ; ahmad@jack.ngo <mailto:ahmad@jack.ngo>=20
Subject: FW: Rejected and not received medicine

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, May 4, 2021 1:28 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >; 'nooromari@jack.ngo' <nooromari@jack.ngo =
<mailto:nooromari@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email and justifications, the attached informal GRN =
shows that the medicines delivered to supplier without pharmacy =
committee and incomplete, but KDZ-AHF team promised to deliver complete =
rejected amount to supplier, the financial cost of this exchange was and =
will be:

1.       Complete exchange cost: 23,530 AFN=20

2.       Incomplete exchange cost: 41,590 AFN

As now the medicine delivered to supplier incompletely, I would like to =
know how we should pay 41,590 AFN to supplier, looking forward to hear =
from you soon.

=20

Dear En. Sahib Hadi,

=20

Kindly refer to below emails and let us know your comments.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, May 3, 2021 9:49 PM
To: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Dear Dr Jamal

=20

As per investigations, I found out there are two problems.

1.       Only 295 flagyl syrups were submitted to Supplier, in this =
case, Haji Naim Jan clininc flagyl syrup were not received although =
Pharmacy assistant delivered Metrogyls, however he says the AOG =
responsible did not give me flagyl syrups

2.       When we delivered the sample medicine to Jan Qataghan of =
Khanabad district for AOG check up, the Salin 500 Ml syrums were sent as =
well, however after rejection, they were not collected back, due to AOG =
said rejected medicine should be replaced in FATP. When we wanted to =
deliver the 1000 Ml syrums of Salin, the pharmacy assistant did not =
collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs that we want =
our 450 Salin 500 mL syrums back, then AOG responsible replied that =
=E2=80=9Cnot collecting back the serums were NGOs fault and now we will =
not give it back we have sealed those serums and we will use it for our =
purpose=E2=80=9D.

=20

The conclusion: Two times the medicine were sent, however they were not =
collected back by Pharmacy assistant.=20

=20

The rest of the decision is up to Kabul Management team what they =
decide, the cleareance of each and every staff is up hold, the decision =
on this section is easy if the AOGs do not give us back serums and =
flagyl syrups.

=20

Currently I am communicating through community access mobilizer, will =
share the result of what is the final words of AOGs by tomorrow CoB.

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792711163

Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Email: <mailto:Parvez.Safar@gmail.com> Parvez.Safar@gmail.com=20

Website:www.jack.ngo

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Monday, May 3, 2021 1:18 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Gentle Reminder!

=20

Dear AHF Team need your response regarding the subject issue, also let =
us know the way you delivered medicine to supplier along with delivered =
amount, looking forward to hear from you soon.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Saturday, May 1, 2021 1:53 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar and Amrullah Khan,

=20

I hope you have been well, based on your request and top management =
approval we have exchanged the rejected medicine to requested medicine =
which your all fully aware of that, now we have pay 23,530 AFN to =
supplier due to exchange rate, to let you know finance team will pay the =
main procurement cost to supplier only exchange cost rate will be paid =
by you as it was agreed, attached is the supplier bank details, if there =
be any question please contact to finance team.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 30, 2021 10:26 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar,

=20

I am glad that you received the requested medicine for 4th Qtr of AHF =
project, which I didn=E2=80=99t get your confirmation nor GRN, please =
let me know about following comments:

1.       Vicryl 4/1 is not available at the market, which size will be =
the alternative (Vicryl size 4 or Vicryl size 1).

2.       Per your request and senior management approval we discussed =
and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml & Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml & Serum-Metro 500mg/30ml) beyond the main contract, =
now supplier is confused that when I will receive the exchanged items =
because he already send his representative three times to PO-M.Stock, in =
order to receive the exchange medicine but due to none reason the =
process get postponed, I would like to know if there is any problem and =
the exact time when your able to deliver the exchanged items to =
supplier.

Please let me know if there is anything that I can help you to =
accelerate the process and close the procurement process.

=20

Best Regards,

=20

JAMAL   Pharm.D

Procurement / Pharmacy Manger

Address: 1st Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 09

What=E2=80=99s app: +93 744 402 619

Email: pharm.dmrjamal@gmail.com <mailto:pharm.dmrjamal@gmail.com> =20

Website:www.jack.ngo=20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 16, 2021 10:13 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo>; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email, please review below comments:

1.       I received the draft of GRN and I found difference at 11 items, =
as I shared the list with supplier he send his representative to PO to =
solve the supply issue immediately, again I will follow this issue with =
supplier and will communicate you via phone.

2.       As we have agreed with supplier to exchange the two items which =
are quarantine right now at P-Stock and you received the replacement, =
please make them ready and pack in exact Qty and good package, please do =
the exchange process in presence of pharmacy committee.

3.       As I already talked with pharmacy team, so please inform them =
to prepare the GRN with all required info such as (expiry date, batch =
number, company & country, Qty, etc..).

4.       As you all aware that AHF-Projects will be audit by 3rd party =
team, so please inform the AHF pharmacy in charge to fully get ready for =
assessment.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, March 15, 2021 6:50 PM
To: logitic.manager@jack.ngo <mailto:logitic.manager@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; pharmacy@jack.ngo =
<mailto:pharmacy@jack.ngo>=20
Subject: Rejected and not received medicine

=20

Dear Dr Sahib Jamal

Greetings from Kunduz office

=20

First of all thank you very much for a very quick procurement of AHF =
trauma medicine, the quality and the quantitiy is good and appreciated.

=20

However, there are difference in 11 items, as we explained and the =
report was shared with the pharmacy/warehouse responsible. I hope it has =
reached to you and I would like to kindly request on the process speed =
up.=20

=20

I would be glad to hear from your dear dr Sahib.

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Mental Health Focal =
Point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 <mailto:Dr.Safar@yahoo.com> =
Dr.Safar@yahoo.com

Website:www.jack.ngo

=20

------=_NextPart_001_009E_01D78B24.247463D0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1>We have to plan a =
meeting on this issue to find the solution way; at first we have to =
draft the assessment report then we will work on this issue please =
remind me .<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>With Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img width=3D49 =
height=3D38 id=3D"Picture_x0020_21" =
src=3D"cid:image002.jpg@01D78B24.219B2C20" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D =
MD,PGD (Leadership) PGD (NMD), =
PMP<o:p></o:p>Program Director =
<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: First Street of Karta-e-Chahar, Kabul =
Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
08<o:p></o:p>Ph: +93 +93(0)748480909 =
<o:p></o:p>Email: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D6 =
height=3D224></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
src=3D"cid:image003.jpg@01D78B24.219B2C20" alt=3D"jack smart code" =
v:shapes=3D"_x0000_s1027"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: dr.safar@jack.ngo =
[mailto:dr.safar@jack.ngo] Sent: Wednesday, August 4, 2021 =
11:01 AM To: ahmad@jack.ngo Cc: hadi@jack.ngo; =
logistic.manager@jack.ngo; fatima.qasimi@jack.ngo; =
finance.manager@jack.ngo; takal@jack.ngo; =
nooromari@jack.ngo Subject: RE: Rejected and not received =
medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p><a =
name=3D"_MailEndCompose">Dear Dr =
Ahmad</a><o:p></o:p><o:p>&nbsp;</o:p>As per below emails and =
justifications, 155 Flagyl syrups and 30 Serum saline were not delivered =
to the supplier according to our exchange plan.<o:p></o:p><o:p>&nbsp;</o:p>The exchange plan was =
to: <o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>450 Flagyl Syrup should have been replaced with =
450 Flagyl solution<o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>2250 saline syrum of 500 Mile liter should have =
been replaced to 2250 Saline syrum 1000 Mile =
Liter<o:p></o:p><o:p>&nbsp;</o:p>295 flagyl syrup was =
delivered to the supplier, however, 155 was missed from Pharmacy =
assistant Mr Hakim Mangal as he said AOGs did not give them the =
exchanged Flagyl syrups.<o:p></o:p><o:p>&nbsp;</o:p>From 2250 Syrums, total =
2220 Syrums were delivered to supplier. 30 syrums remained from the =
exchange, the reasons was when the first supply happened to Jan =
Qataghan, the syrums of 1000 Mile Liter was sent, however, the exchange =
of it was not brought back to stock. Later AOGs only gave them 420 =
syrums, 30 was used by FATP staff.<o:p></o:p><o:p>&nbsp;</o:p>Total: 155 Flagyl syrup and 30 Saline 500 Mile liter =
was left and the reason was that Mr Hakim Mangal sent the medicine to =
FATPs and did not bring back it=E2=80=99s exchange, he said AOGs did not =
permit.<o:p></o:p>The real was that Mr Mangal reported the issue =
after 3 days. When the issue was followed up, FATP staff said we have =
submitted and there were no documents for hand over/take over. Not =
having a clear document for takeover of medicine was the fault of =
Pharmacy assistant.<o:p></o:p><o:p>&nbsp;</o:p>Conclusion: =
&nbsp;I would like to kindly =
request from top management team that declare their decision on the =
above mentioned issue. As it was raised by myself even months ago and =
there is no clear decision taken until now.<o:p></o:p><o:p>&nbsp;</o:p>Thanks in =
advance<o:p></o:p><o:p>&nbsp;</o:p><div>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D61 =
height=3D48 id=3D"_x0000_i1025" =
src=3D"cid:image007.jpg@01D78B24.21949C70" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Emergency projects focal point / COVID-19 =
Vaccination technical focal point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93790807013 =E2=80=93 +93777 469 663<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: &nbsp;<a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
/div><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, June 21, 2021 8:30 AM To: <a =
href=3D"mailto:fatima.qasimi@jack.ngo">fatima.qasimi@jack.ngo</a> C=
c: <a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a> Subject: FW: =
Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, May 4, 2021 1:28 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt;; =
'nooromari@jack.ngo' &lt;<a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a>&gt; Subje=
ct: RE: Rejected and not received =
medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email =
and justifications, the attached informal GRN shows that the medicines =
delivered to supplier without pharmacy committee and incomplete, but =
KDZ-AHF team promised to deliver complete rejected amount to supplier, =
the financial cost of this exchange was and will =
be:<o:p></o:p><![if =
!supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Complete exchange cost: 23,530 AFN =
<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Incomplete exchange cost: 41,590 =
AFN<o:p></o:p>As now the medicine delivered to supplier =
incompletely, I would like to know how we should pay 41,590 AFN to =
supplier, looking forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Dear En. Sahib =
Hadi,<o:p></o:p><o:p>&nbsp;</o:p>Kindly refer to below =
emails and let us know your comments.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 9:49 PM To: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Jamal<o:p></o:p><o:p>&nbsp;</o:p>As per investigations, I =
found out there are two problems.<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Only 295 flagyl syrups were submitted to =
Supplier, in this case, Haji Naim Jan clininc flagyl syrup were not =
received although Pharmacy assistant delivered Metrogyls, however he =
says the AOG responsible did not give me flagyl =
syrups<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When we delivered the sample medicine to Jan =
Qataghan of Khanabad district for AOG check up, the Salin 500 Ml syrums =
were sent as well, however after rejection, they were not collected =
back, due to AOG said rejected medicine should be replaced in FATP. When =
we wanted to deliver the 1000 Ml syrums of Salin, the pharmacy assistant =
did not collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs =
that we want our 450 Salin 500 mL syrums back, then AOG responsible =
replied that =E2=80=9Cnot collecting back the serums were NGOs fault and =
now we will not give it back we have sealed those serums and we will use =
it for our purpose=E2=80=9D.<o:p></o:p><o:p>&nbsp;</o:p>The conclusion: Two =
times the medicine were sent, however they were not collected back by =
Pharmacy assistant. <o:p></o:p><o:p>&nbsp;</o:p>The rest of the decision =
is up to Kabul Management team what they decide, the cleareance of each =
and every staff is up hold, the decision on this section is easy if the =
AOGs do not give us back serums and flagyl =
syrups.<o:p></o:p><o:p>&nbsp;</o:p>Currently I am =
communicating through community access mobilizer, will share the result =
of what is the final words of AOGs by tomorrow =
CoB.<o:p></o:p><o:p>&nbsp;</o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF =
Project<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792711163<o:p></o:p>Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Email: <a =
href=3D"mailto:Parvez.Safar@gmail.com">Parvez.Safar@gmail.com</a> <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
div><div style=3D'border:none;border-top:solid #E1E1E1 =
1.0pt;padding:3.0pt 0in 0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 1:18 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Gentle Reminder!<o:p></o:p><o:p>&nbsp;</o:p>Dear AHF Team need your =
response regarding the subject issue, also let us know the way you =
delivered medicine to supplier along with delivered amount, looking =
forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Saturday, May 1, 2021 1:53 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar and Amrullah =
Khan,<o:p></o:p><o:p>&nbsp;</o:p>I hope you have been =
well, based on your request and top management approval we have =
exchanged the rejected medicine to requested medicine which your all =
fully aware of that, now we have pay 23,530 AFN to supplier due to =
exchange rate, to let you know finance team will pay the main =
procurement cost to supplier only exchange cost rate will be paid by you =
as it was agreed, attached is the supplier bank details, if there be any =
question please contact to finance team.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 30, 2021 10:26 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar,<o:p></o:p><o:p>&nbsp;</o:p>I am glad that you =
received the requested medicine for 4th Qtr of AHF project, =
which I didn=E2=80=99t get your confirmation nor GRN, please let me know =
about following comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Vicryl 4/1 is not available at the market, which =
size will be the alternative (Vicryl size 4 or Vicryl size =
1).<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Per your request and senior management approval =
we discussed and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml &amp; Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml &amp; Serum-Metro 500mg/30ml) beyond the main =
contract, now supplier is confused that when I will receive the =
exchanged items because he already send his representative three times =
to PO-M.Stock, in order to receive the exchange medicine but due to none =
reason the process get postponed, I would like to know if there is any =
problem and the exact time when your able to deliver the exchanged items =
to supplier.<o:p></o:p>Please let me know if there is anything that I =
can help you to accelerate the process and close the procurement =
process.<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 id=3D"Picture_x0020_1" =
src=3D"cid:image008.jpg@01D78B24.21949C70" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>JAMAL&nbsp;&nbsp; Pharm.D<o:p></o:p>Procurement / Pharmacy =
Manger<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: 1st Street of Karta-e-Chahar, =
Kabul Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
09<o:p></o:p>What=E2=80=99s app: +93 744 402 =
619<o:p></o:p>Email: <a =
href=3D"mailto:pharm.dmrjamal@gmail.com">pharm.dmrjamal@gmail.com</a></sp=
an>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D6 =
height=3D2439></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
src=3D"cid:image006.jpg@01D78B24.219B2C20" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 16, 2021 10:13 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email, =
please review below comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>I received the draft of GRN and I found =
difference at 11 items, as I shared the list with supplier he send his =
representative to PO to solve the supply issue immediately, again I will =
follow this issue with supplier and will communicate you via =
phone.<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As we have agreed with supplier to exchange the =
two items which are quarantine right now at P-Stock and you received the =
replacement, please make them ready and pack in exact Qty and good =
package, please do the exchange process in presence of pharmacy =
committee.<o:p></o:p><![if =
!supportLists]>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As I already talked with pharmacy team, so =
please inform them to prepare the GRN with all required info such as =
(expiry date, batch number, company &amp; country, Qty, =
etc..).<o:p></o:p><![if =
!supportLists]>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As you all aware that AHF-Projects will be audit =
by 3rd party team, so please inform the AHF pharmacy in =
charge to fully get ready for assessment.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, March 15, 2021 6:50 PM To: <a =
href=3D"mailto:logitic.manager@jack.ngo">logitic.manager@jack.ngo</a> =
Cc: <a href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> Subject:</b=
> Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Jamal<o:p></o:p>Greetings from Kunduz =
office<o:p></o:p><o:p>&nbsp;</o:p>First of all thank you very much for a very quick =
procurement of AHF trauma medicine, the quality and the quantitiy is =
good and appreciated.<o:p></o:p><o:p>&nbsp;</o:p>However, =
there are difference in 11 items, as we explained and the report was =
shared with the pharmacy/warehouse responsible. I hope it has reached to =
you and I would like to kindly request on the process speed up. =
<o:p></o:p><o:p>&nbsp;</o:p>I would be glad to hear from your dear dr =
Sahib.<o:p></o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D49 =
height=3D38 id=3D"_x0000_i1027" =
src=3D"cid:image011.jpg@01D78B24.21949C70"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Mental Health Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =
=E2=80=93 <a href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_009E_01D78B24.247463D0--

------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/png;
	name="image004.png"
Content-Transfer-Encoding: base64
Content-ID: <image004.png@01D78B24.21949C70>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image007.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image007.jpg@01D78B24.21949C70>
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------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image008.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image008.jpg@01D78B24.21949C70>
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------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image011.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image011.jpg@01D78B24.21949C70>
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------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image002.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image002.jpg@01D78B24.219B2C20>
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------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image003.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image003.jpg@01D78B24.219B2C20>

/9j/4AAQSkZJRgABAQEAkACQAAD/2wBDAAoHBwkHBgoJCAkLCwoMDxkQDw4ODx4WFxIZJCAmJSMg
IyIoLTkwKCo2KyIjMkQyNjs9QEBAJjBGS0U+Sjk/QD3/wAALCACKAIoBAREA/8QAHwAAAQUBAQEB
AQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1Fh
ByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZ
WmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXG
x8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/9oACAEBAAA/APZqKKKKKKKKKKKKKKKK
KKKKKKKKKKKKKKKKKKKKK8w+JfxL1bwb4gt7DT7azliltlmJmVi2SzDsw4+UVyv/AAu7xX/0CrD/
AL8S/wDxVH/C7vFf/QKsP+/Ev/xVB+N/ioDJ0qwx/wBcJf8A4qu0+F/xC1PxteahFqNvaRLbRoyG
BWBJJI5yT6VDovxI1TUfilP4amt7NbOOeeISKreZhAxHO7H8I7UnjH4kar4e8e2miWlvZvbTeTue
RWLje2DghgP0r0mSWOLHmSKmem44zXOeP/Etz4W8JTarYJDLKjoqiUEqQxx2IrypPjl4okXcmmae
y+qwyEf+h07/AIXd4r/6BVh/34l/+Ko/4Xd4r/6BVh/34l/+Kq5oXxn8Qal4k07Trqx0+NLm5jhf
EbhgGYA4y3XmvbaKKKK8G+N3/JQNM/69I/8A0Y9ep+N/G9t4Isra5urWa4W4kMYEbAYIGe9cb/wv
/S/+gPe/99pXXaD4tg8Z+D7/AFG2tpbdFEsOyQgnIQHPH1rzr9n7/kJ61/1xj/8AQmrS1LwvP4C8
V33jy7uIrm0W4kk+zRAiQiUlQMnjjeM/SuG8QeKoPGHxH03U7a3kt08yCPZIQTkP14+tdp+0F/x7
aF/vz/yStDx3/wAkIsP+vaz/AJLVv4UXq6b8JmvXRnW2NxMVXqwXJwPyrO/4X/pf/QHvf++0rc8I
fFax8X64umW2n3MEhjaTfIykYH0rgvGH/JwFl/192f8AJK95oooorwb43f8AJQNM/wCvSP8A9GPX
Q/H/AP5AOk/9fLf+g14XXvXwf/5JZqX/AF3n/wDRa1hfs/f8hPWv+uMf/oTVTk8Wf8XR1Gw8VajL
L4eS7uEe2n3SRYBbYNoB6MFx9K6uLXvhNBKksSackiMGVhZSZBHQ/dq/qvjr4c66Ihqt1a3Yhz5f
nWsjbc4zj5fYflUfxVe1k+Eu/Twos2+zmAKMDy8jbgdhjFUvh9/yQ3UP+uF3/wCgtXgteg/BL/ko
Uf8A17S/0rS8Yf8AJwFl/wBfdn/JK95oooorwb43nHj/AEzPT7JH/wCjHr0/xZoXh7xna29vqmoq
qQOXTybhFOSMc5zXLf8ACoPA/wD0FLn/AMDI/wD4mul0nStC8JeFb7TtMv0eJ1kl/fXCM24rjtj0
Feffs/f8hPWv+uMf/oTV1eo/CfwnrOt3dzNfXRvLmZ5ZI47lOGJJIA25ryP4j+F7Pwr4r/szTDO8
RhRx5rBmLHPoB6VzE9pcW237RBLFu6b0K5/OvdfHn/JCbD/r2s/5LU3wqewufhd9gvbqKJbhp4nB
lVWCsSDjPsag/wCFQeB/+gpc/wDgZH/8TWv4Z8C+FPCmrjUtO1J2nCMmJbqNlwevAArz/wAVzRz/
AB8sZIZEkQ3dnhkYEfwdxXvlFFFFedfEL4X3HjbXIL+HUorVYrcQ7HiLEkMxznP+1XK/8M/Xv/Qc
t/8Avw3+NH/DP17/ANBy3/78N/jR/wAM/Xv/AEHLf/vw3+Ndl8OfhzP4Gu76aa/juhcoqgJGV24J
Pc+9RaR8MrjTPiRN4nbUIniknnl8gREMPMDDGc9t1Hiv4Z3HiPxta67HqMUCQeV+6aIknY2eue9c
/wDtBf8AHtoX+/P/ACSurvfDMni74U6XpUVwtu0lpat5jLuA2qp6Vw//AAz9e/8AQct/+/Df40f8
M/Xv/Qct/wDvw3+NH/DP17/0HLf/AL8N/jV7Q/gfeaRr1hqDazBItrcRzFBAQWCsDjOfavYaKKKK
5nxP480LwxObLVLx4LqSHzEVYnbg5AOQMdQa8N8O33jzxXcTQaPrGpTyQoHcG+KYGcfxMK7nxB8Q
YdN+H8uiSardR+KbeKOKUrv3iVWXf+8HB4B5zzXl3/CceJ/+hg1T/wACn/xr1D4I69qus6jqy6nq
N3eLHFGUE8rOFJJzjNZHju18f6Nfatq39oX8Gji5YxFL7hUZ8JhQ2R1HGOKq+D4PiF4he01K01LU
J9OW5VZWe/xkKRuG0tk8V7nqWiaZrIjGqWFteCLOwTxB9ueuM9Ogrx/VPCnxLXVbwaTcXkOnidxa
xx6gqKkW47AF3cALjjtXUeE/FyeGrW28P+ML+f8At95sbZN0xIdvk+cZHf14qx8TdK8Xam+mnwlP
cRCMSfaPJuhDnO3bnJGejVd8Wad4ku/AVra6NLMmsqIfNdLgIxIX5/nyM8+/NcPoPhr4mweINOl1
K7vmskuY2nDaiGBjDDdkbueM8V7TRRRRXhvxq0u7v/G1g0FnczQizRXeOJmA/ePnkD0q9rFpbfDq
GO7+H7/bru6byrhd32nag5BwvTnvXBaHDF4q+I6r4nP2dbyWR7rnydrbGPfpyBV/xl4MstP8V2tt
4eiubvS3jjMs0beaqsWIYb1GBgYr13wroXhHwdNcS6VqkO64UK/m3iNwORj86q/FO+tdV8AX9ppt
1Bd3LtEVht5BI7YkUnCjk8c15v4L8UeLfDSWul2+nPHYNchpXmtHyoYjcS3YYrvPid8Rbnw3Fpre
HruwnM7SCYZEuMbcdDx1NccnxT8fyxq8enK6MAVZbByCPUGuj07w6fFWgS+MtbtrlPENsryRRqpR
S0QzH+7IyeQPrW78MfE/iDxIupHxDbeQYDH5P+jtFnO7d169BWb4b8deILnxxdWOuRRWukxtMEmk
gMQO1sL85OOf1r0CPW9LmkWOLUrN3c7VVZ1JJ9AM1eoooopkyebC6A43KVz6Zrhfh78NX8Dahd3L
6kt4LiIR7RDs24Oc/eNcZ8TPhjJaR614pOqKytL532fyMH53C43bu2fSsLwb8To/CnhS50dtLa5a
eSR/NE+zG5QvTafT1rM8A+A38dXN5El+tn9lRWyYt+7JI9RjpXcR+A3+FDjxbLfrqS2Xy/Zli8ov
5nyfey2Mbs9O1Sn43Ra4p0oaI8Jvv9GEhuQ2zf8ALnG3nGelV/8Ahn2b/oYI/wDwEP8A8XXoWt6w
Ph74Et55ITffYoobYgN5e/AC56HHrirfgzxOvi/w9Hqq2ptQ7snll9+Npx1wK3q8++Nv/JPX/wCv
mL+tcR8Nfhi+rQaT4mGppGsV0Jfs5gyT5cnTdu77fSveKKKKK80+Ivh7xdqfiO2u/D91PDYRW6iV
Y7wxAsGYn5cjPBFdR4a8d6J4tuZoNInlkkhQO4eJlwM471wuqaVrmj+NLzXfEk0kvhJJ3eSB5/OQ
o2VT9zk5+Yrxjjr2rzv4jaroeseJI7jw3DHFZi3VGWODyhvBbPy4HYjmofBeieJNanul8MXEsMka
qZjHc+TkEnHcZ7165B8RfDOnaLBoXieWS5vbSNYLxJrczK0qYDZJBDfMOv40ln43+G019BFa2FoJ
3kVYyNNAIYnjnbxzVP46arf6Xb6KdPvrm1MjTb/IlZN2AmM4PPU11j6tpdh8ONMvvEqi4tGtbcy+
dF525iq4JBzk571kWnxa8DafAILJ2t4QSRHDZlFBPXgDFT/8Ln8If8/lx/4DP/hUF58WfA2oQeRe
u1zDnPlzWZdc+uCKsaL8TvBr3Frpeks0JmlEcUUdoUTcxx0AwOTXd0UUUVDd/wDHnP8A9c2/lXiP
wA/5D2rf9ey/+hV6H8Wf+Saav9I//RqV8yV6n8C9TsdN1HV2v7y2tVeKMKZ5VTdyemTzXaz+AvAP
iLWZ51vIrm9u5GlZIb8MWY5JwoP1ovPhN4Y0ixn1G0t7hbm0jaeItOxAdRuGR35Arm/BcjfF6S8j
8Xfv100I1v5H7rBfO7OOv3Frpfi1Zxaf8Kns7cEQ25gijBOSFUgDn6CuX+HXw68OeIPBUeq6vHL5
u+QPIJyihVPU9hxWx/wr/wCGf/QStv8AwZr/AI1PafDL4eX8/k2VylxLjOyHUA7Y9cA1wOpaFZeG
/jVpum6ajpbRXlqVDsWPJUnn6mvoqiiiivO/iH8TW8G6qmmDSxdCe283zDPsxksuMbT6V5F4B8cH
wNf3dytiLz7REI9pl2bcHOehr1/xzqp134KXOpmHyTdW8Mvl7t23MicZ4zXzrRXunwz+GS6ZPpHi
j+0zIZLbzfs/kYx5kZGN27tu9K9Qv7X7dp1za79nnxNHuxnbuBGcfjXkLxf8KKxKh/tg6t8uD+48
ry+f9rOd/t0re+KN/wD2p8IEv9nl/altptmc7dxBxnv1qr8P/wDkhuof9cLv/wBBavBa9A+CX/JQ
o/8Ar2l/pWn4w/5OAsv+vuz/AJJXvNFFFFeWfEz4fa14q8V2d/pqW7W8Nukb+ZLtOQ7E8Y9CK9B/
4RzRv+gRp/8A4DJ/hXz74gs9W134jal4c0y5kWKS6kSK2aYpCqrlsbegA28DFYOveE9S8N61DpWo
CIXUyqyhH3DDEgc/UV0//CkvFn/POy/8CP8A61b3ibx1Zad8Pf8AhFYLi7h1uwjhtZGiBVQ8bKHw
4PT5Tz3rpvhZLfar8L7sNczTXcjzxxySyksCVAHzHkc1z+jI/wAPDM/xGP25L3Asw3+lbCud/wB7
7udy/XHtXRfFW4t7z4S/abNdttN9nkiXbtwhIKjHbjHFQfDK0lv/AIN3FpAAZrhbmJAxwNzAgZP1
NcB/wpLxZ/zzsv8AwI/+tXWfDX4a694W8WpqGpJbC3ELoTHLuOTjHGKxfGH/ACcBZf8AX3Z/ySve
aKKKKjnLLBIY/vhSV4zzivPvhprfjHVdSvU8VW9xFAkIMRltPJBbPODgZ4rmtJ0DVovjxJqEmmXi
2RvJ2FwYWEeCjAHdjGDkUnxT0DVtR+JFhdWOmXlxbpDCGlihZlBEjE5IGK7P4mat4n0q0sG8KwTy
ySO4nEVt52AAMZ4OO9VdN+GGg65pttqmu6fP/at5Es93uleM+awy/wAoIC8k8Y4rG1CPxH4M8UWm
jeD7G7XQGeN5CtsZlBZsP85BI4HrxU3xx0bUtXt9GGm2F1dmNpt/kRM+3ITGcdOhq7400q/u/gxZ
WNvZXEt4sFqGgSMlwQFyCo54rz3QtS+I/hvTF0/S9M1CK2RiwU6cWOScnkrmtH/hMPit/wA+N/8A
+Csf/E0f8Jh8Vv8Anxv/APwVj/4ms3TtO8Xaz8RNL1fWtJ1DzPtkBlmNmyKFVlGTgAAACvouiiii
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiv//Z

------=_NextPart_000_009D_01D78B24.247463D0
Content-Type: image/jpeg;
	name="image006.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image006.jpg@01D78B24.219B2C20>

/9j/4AAQSkZJRgABAQEAkACQAAD/2wBDAAoHBwkHBgoJCAkLCwoMDxkQDw4ODx4WFxIZJCAmJSMg
IyIoLTkwKCo2KyIjMkQyNjs9QEBAJjBGS0U+Sjk/QD3/wAALCACKAIoBAREA/8QAHwAAAQUBAQEB
AQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1Fh
ByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZ
WmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXG
x8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/9oACAEBAAA/APZqKKKKKKKKKKKKKKKK
KKKKKKKKKKKKKKKKKKKKK8w+JfxL1bwb4gt7DT7azliltlmJmRi2SzDsw4+UVyv/AAu7xX/0CrD/
AL8S/wDxVH/C7vFf/QKsP+/Ev/xVIfjf4qAydKsMf9cJf/iq7X4X/ELU/G15qEWowWkS20aMhgVg
SSSOck+lQ6L8R9V1H4pz+GprezWzjnniDqreZhAxHO7H8I7UnjL4kar4e8e2miWlvZvbTeTueRWL
je2DghgP0r0mSWOLHmSKmem44zXOeP8AxLc+FvCU2q2CQyyo6KolBKkMcdiK8qT45eKJF3Jpmnsv
qsMhH/odO/4Xd4r/AOgVYf8AfiX/AOKo/wCF3eK/+gVYf9+Jf/iquaF8ZvEOpeJNO066sdPjS5uY
4XxG4YBmAOMt15r22iiiivBvjd/yUDTP+vSP/wBGPXqfjfxvbeCLK2ubq1muFuJDGBGwGCBnvXG/
8L/0v/oD3v8A32lddoPi2Dxn4Pv9RtraW3RRLDskIJyEBzx9a86/Z+/5Cetf9cY//QmrS1LwvP4C
8V33jy7uIrm0W4kk+zRAiQiUlQMnjjeM/SuG8QeKoPGHxH03U7a3kt08yCPZIQTkP14+tdp+0F/x
7aF/vz/yStDx3/yQiw/69rP+S1b+FF6um/CZr10Z1tjcTFV6sFycD8qzv+F/6X/0B73/AL7Stzwh
8VrHxfri6ZbafcwSGNpN8jKRgfSuC8Yf8nAWX/X3Z/ySveaKKKK8G+N3/JQNM/69I/8A0Y9dD8f/
APkA6T/18t/6DXhde9fB/wD5JZqX/Xef/wBFrWF+z9/yE9a/64x/+hNVOTxZ/wAXR1Gw8VajLL4e
S7uEe2n3SRYBbYNoB6MFx9K6uLXvhNBKksSackiMGVhZSZBHQ/dq/qvjr4c66Ihqt1a3Yhz5fnWs
jbc4zj5fYflUfxVe1k+Eu/Twos2+zmAKMDy8jbgdhjFUvh9/yQ3UP+uF3/6C1eC16D8Ev+ShR/8A
XtL/AErS8Yf8nAWX/X3Z/wAkr3miiiivBvjeceP9Mz0+yR/+jHr0/wAWaF4e8Z2tvb6pqKqkDl08
m4RTkjHOc1y3/CoPA/8A0FLn/wADI/8A4mul0nStC8JeFb7TtMv0eJ1kl/fXCM24rjtj0Feffs/f
8hPWv+uMf/oTV1eo/CfwnrOt3dzNfXRvLmZ5ZI47lOGJJIA25ryP4j+F7Pwr4r/szTDO8RhRx5rB
mLHPoB6VzE9pcW237RBLFu6b0K5/OvdfHn/JCbD/AK9rP+S1N8KnsLn4XfYL26iiW4aeJwZVVgrE
g4z7GoP+FQeB/wDoKXP/AIGR/wDxNa/hnwL4U8KauNS07UnacIyYluo2XB68ACvP/Fc0c/x8sZIZ
EkQ3dnhkYEfwdxXvlFFFFedfEL4X3HjbXIL+HUorVYrcQ7HiLEkMxznP+1XK/wDDP17/ANBy3/8A
Adv8aP8Ahn69/wCg5b/+A7f40f8ADP17/wBBy3/8B2/xrsvhz8OZ/A13fTTahHdC5RVASMrtwSe5
96i0j4ZT6Z8SJvE7ahE8ck88vkCIgjzAwxnPbdR4r+Gdx4j8bWuux6jFAkHlfumiJJ2NnrnvXP8A
7QX/AB7aF/vz/wAkrq7zwzJ4u+FOl6VFcLbtJaWreYy7gNqqelcP/wAM/Xv/AEHLf/wHb/Gj/hn6
9/6Dlv8A+A7f40f8M/Xv/Qct/wDwHb/Gr2h/A+70jXrDUG1mCRbW4jmKCAgsFYHGc+1ew0UUUVzP
ifx5oXhic2WqXjwXUkPmIqxO3ByAcgY6g14b4dvfHniu4mg0fWNSnkhQO4N8UwM47sK7nxB8QYdN
+H8uhyardR+KbeKOKUrv3iVWXf8AvBweAec815d/wnHif/oYNU/8Cn/xr1D4I69qus6jqy6nqN3d
rHFGUE8rOFJJzjJrI8d2vj/Rr7VtW/tC/g0gXLGIpfcKjPhMKGyOo4xxVXwfB8QfEL2mpWmpahPp
63KrKz3+MhSNw2lsnivc9S0TTNZEY1SwtrwRZ2CeIPtz1xnp0FePap4T+Ja6reDSri8h08TuLWOP
UFRUi3HYAu7gBccdq6nwn4uTw1a23h/xhfz/ANvvNjbJumJDt8nzjI7+vFWPibpPi3U300+Ep7iI
RiT7R5N0Ic527c5Iz0arvizTvEl34CtbXRpZk1lRD5rpcBGJC/P8+Rnn35rh9B8NfE238QadLqN3
fNZJcxtOG1EMDGGG7I3c8Z4r2miiiivDfjVpd3f+NrBoLO5mhFmiu8cTMB+8fPIHpV7WLS2+HUMd
38P3+3Xd03lXC7vtO1ByDhenPeuC0OGLxV8R1XxOfs63csj3XPk7W2Me/TkCr/jLwZZaf4rtbbw9
Fc3elvHGZZo281VYsQw3qMDAxXr3hXQvCPg6a4l0rVIA1woV/NvEbgcjH51U+Kd9a6r4Av7TTbqC
7uXaIrDbyCR2xIpOFHJ45rzbwX4o8W+GktdLt9PeOwa5DSvNaPlQxG4luwxXe/E74i3PhuLTW8PX
ljOZ2kEwyJcY246Hjqa45Pin4/ljV49ODowBVlsHII9Qa6PTvDp8VaBL4y1u2uU8Q2yvJFGqlFLR
DMf7sjJ5A+tbvwx8T+IPEi6kfENt5BgMfk/6O0Wc7t3Xr0FZvhvxz4gufHN1Y65FFa6TG0wSaSAx
A7Wwvznjn9a9Aj1vS5pFji1Kzd3O1VWdSSfQDNXqKKKKZMnmwugONylc+ma4X4e/DV/A2oXdy+pL
eC4iEe0Q7NuDnP3jXGfEz4YyWketeKTqisrS+d9n8jB+dwuN27tn0rC8G/E6Pwp4UudHbS2uWnkk
fzRPsxuUL02n09azPAPgN/HVzeRJfrZ/ZUVsmLfuySPUY6V3EfgN/hQ48Wy366ktl8v2ZYvKL+Z8
n3stjG7PTtUp+N0WuKdKGiPCb7/RhIbkNs3/AC5xt5xnpVf/AIZ9m/6GCP8A8BD/APF16FresD4e
+BLeeSE332KKG2IDeXvwAuehx64q34M8Tr4v8PR6qtqbUO7J5ZffjacdcCt6vPvjb/yT1/8Ar5i/
rXEfDX4Yvq0Gk+JhqaRrFdCX7OYMk+XJ03bu+30r3iiiiivNPiL4e8Xan4jtrvw/dTw2EVuolWO8
MQLBmJ+XIzwRXUeGvHeieLbmaDSJ5ZJIUDuHiZcDOO9cLqmla5o/jS813xJNJL4SSd3kgefzkKNl
U/c5OfmK8Y469q87+I2q6HrHiSO48NwxxWYt1Rljg8obwWz8uB2I5qHwXoniTWp7pfDFxLDJGqmY
x3Pk5BJx3Ge9euQfEXwzp2iwaF4nlkub20jWC8Sa3MytKmA2SQQ3zDr+NJZ+N/htNfQRWthaCd5F
WMjTQCGJ4528c1T+Omq3+l2+inT765tTI02/yJWTdgJjODz1NdY+raXYfDjTL7xKouLRrW3MvnRe
duYquCQc5Oe9ZFp8WvA2nwCCydreEEkRw2ZRQT14AxU//C5/CH/P5cf+Az/4VBefFnwNqEHkXrtc
w5z5c1mXXPrgirGi/E7wa9xa6XpLNCZpRHFFHaFE3McdAMDk13dFFFFQ3f8Ax5z/APXNv5V4j8AP
+Q9q3/Xsv/oVeh/Fn/kmmr/SP/0alfMlep/AvU7HTdR1dr+8trVXijCmeVU3cnpk812s/gLwD4i1
medbyK5vbuRpWSG/DFmOScKD9aLz4TeGNIsZ9RtLe4W5tI2niLTsQHUbhkd+QK5vwXI3xekvI/F3
79dNCNb+R+6wXzuzjr9xa6X4tWcWn/Cp7O3BENuYIowTkhVIA5+grl/h18OvDniDwVHqurxy+bvk
DyCcooVT1PYcVsf8K/8Ahn/0Erb/AMGa/wCNT2nwy+Hl/P5NlcpcS4zsh1AO2PXANcDqWhWXhv41
abpumo6W0V5alQ7FjyVJ5+pr6Koooorzv4ifE1vBuqppg0sXQntvN8wz7MZLLjG0+leReAfHB8DX
93crYi8+0RCPaZdm3Bznoa9f8c6qdd+ClzqZh8k3VvDL5e7dtzInGeM1860V7p8M/hkumT6R4o/t
MyGS2837P5GMeZGRjdu7bvSvUL+1+3adc2u/Z58TR7sZ27gRnH415C8X/CisSof7YOrfLhv3HleX
z/tZzv8AbpW98UL/APtT4QJf7PL+1LbTbM527iDjPfrVX4f/APJDdQ/64Xf/AKC1eC16B8Ev+ShR
/wDXtL/StPxh/wAnAWX/AF92f8kr3miiiivLPiZ8Pta8V+K7O/01LZreG3SN/Nl2nIdieMehFeg/
8I7o3/QI0/8A8Bk/wr598QWeq678RtS8OaZcyLFJdSJFbNMUhVVy2NvQAbeBisHX/CepeG9ah0rU
BELqZVZQj7lwxIHP1FdP/wAKS8Wf887L/wACP/rVveJvHVlp3w9/4RWC4u4dbsI4bWRogVUPGyh8
OD0+U8966b4WS32q/C+7DXMs13I88cckspLAlQB8x5HNc/oyP8PDM/xGP25L3Asw3+lbCud/3vu5
3L9ce1dF8Vbm3vPhL9ps122032eSJdu3CEgqMduMcVB8MrSW/wDg3cWkABmuFuYk3HA3MCBk/U1w
H/CkvFn/ADzsv/Aj/wCtXWfDX4a694W8WpqGpJbC3ELoTHLuOTjHGKxfGH/JwFl/192f8kr3miii
io5yywSGP74UleM844rz74aa34x1TUr1PFVvcRQJCDEZbTyQWzzg4GeK5rSdA1aL48SajJpl4tib
ydvtBhYR4KMAd2MYORR8U9A1bUfiRYXVjpl5cW6QwhpYoWZQRIxOSBiuy+JmreJ9KtLBvCkM8sju
4nEVt52BgYzwcd6q6b8MNB1zTbbVNd06f+1byJZ7zdK8Z81hl/lBAXknjHFY2oxeI/Bnii00bwfY
3a6AzxvIVtjMoLNh/nIJHA9eKm+OOjalq9vow02wursxtNv8iJn25CYzjp0NXfGmlX938GLKxt7K
4lvFgtQ0CRkuCAuQVHPFee6FqPxH8N6Yun6XpmoRWyMWCnTt3JOTyVzWj/wl/wAVv+fG/wD/AAVj
/wCIo/4S/wCK3/Pjf/8AgrH/AMRWbp2m+LtZ+Iml6vrWk6h5n2yAyzGzZFCqyjJwAAABX0XRRRRR
RRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRX/9k=

------=_NextPart_000_009D_01D78B24.247463D0--